Publications - IR Sant Pau

Search

04/12/2025 Ultrasound-Based Assessment of Posterior Vitreous Detachment in Healthy Eyes: Clinical and Biometric Factors Associated with More Advanced PVD

Rodriguez-Vidal, C, Alday, NM, Teijeiro, MJB, Bande, M. Ultrasound-Based Assessment of Posterior Vitreous Detachment in Healthy Eyes: Clinical and Biometric Factors Associated with More Advanced PVD. Journal of Clinical Medicine. 2025; 14(23)DOI:10.3390/jcm14238587. PMID:41375890. IF:2.900(Q1/2D).

01/11/2025 Sutureless scleral fixation of intraocular lenses in microspherophakia: The Yamane technique

Caminal-Caramés, M, Vilimelis, JC, Segarra, JIV, Pernias, AS, Conversa, S. Sutureless scleral fixation of intraocular lenses in microspherophakia: The Yamane technique. JOURNAL FRANCAIS D OPHTALMOLOGIE. 2025; 48(9)DOI:10.1016/j.jfo.2025.104668. PMID:41130818. IF:1.100(Q3/8D).

01/08/2023 International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer's Disease.

Tian M, Zuo C, Civelek AC, Carrio I, Watanabe Y, Kang KW, Murakami K, Garibotto V, Prior JO, Barthel H, Guan Y, Lu J, Zhou R, Jin C, Wu S, Zhang X, Zhong Y, Zhang H. International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer's Disease.. PHENOMICS. 2023; 3(4)DOI:10.1007/s43657-022-00068-9. PMID:37589025. IF:(Q/D).

01/08/2021 Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

Astigarraga, PMO, Lerma, FA, Zambrano, CB, Costa, RG, Vidal, FG, Navarro, RD, Suarez, CR, Pallas, TA, Montero, JG, Vera-Artázcoz P., Alemparte Pardavila, Enrique. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study. Medicina Intensiva. 2021; 45(6)DOI:10.1016/j.medin.2020.01.013. PMID:32307264. IF:2.799(Q3/7D).

01/01/2026 Determinants in the decision of intensive care admission of cancer patients: A spanish multicenter prospective study

Fito, EC, Mayor-Vázquez, E, Lagares, CD, Tegedor, BV, Martin, NIL, Fernández, AL, Montori, LS, Isern, I, Carrillo, AC, Gómez, JS, Grande, MLG, Rodriguez, AF, Espejo, A, Diaz, DD, Roche, AG, Márquez, M, Cortés, MM, Valero, N, Romero, MG, Abalde, FE, Lucas, JH, Martinez, NA, Quintana, MDJ, Gallego, AO, Casa, RMD, Donaire, DM, Aledo, ALGD, Casas, AB, Sigwalda, LL, Sánchez, SP, Ruiz, AB, Lipperheide, I, Varas, JL, Pérez, PR, Gómez-Acebo, I. Determinants in the decision of intensive care admission of cancer patients: A spanish multicenter prospective study. Medicina Intensiva. 2026; 50(1)DOI:10.1016/j.medin.2025.502344. PMID:. IF:3.100(Q2/3D).

01/01/2026 Cytokine release syndrome and hemophagocytic syndrome associated with immunotherapy: A narrative review

Mayor-Vázquez, E, Fito, EC, Marcos-Neira, P, Díaz-Lagares, C, Gomila-Sintes, C, Albalá, N, García-Roche, A, Castro, P. Cytokine release syndrome and hemophagocytic syndrome associated with immunotherapy: A narrative review. Medicina Intensiva. 2026; 50(1)DOI:10.1016/j.medin.2025.502254. PMID:40946001. IF:3.100(Q2/3D).

01/11/2025 Longitudinal Characterization of Patient-Ventilator Asynchronies in Acute Hypoxemic Respiratory Failure

de Haro, C, Xifra-Porxas, A, Batlle, M, Sarlabous, L, Santos-Pulpón, V, Mora, V, Suñol, F, Gomà, G, Estela, J, Subirà, C, López-Aguilar, J, Fernández-Gonzalo, S, Godoy-González, M, Fernández, R, Magrans, R, Telias, I, Roca, O, Brochard, L, Blanch, L. Longitudinal Characterization of Patient-Ventilator Asynchronies in Acute Hypoxemic Respiratory Failure. Respiratory Care. 2025; 70(11)DOI:10.1089/respcare.12673. PMID:40441677. IF:2.100(Q3/6D).

01/12/2023 Association between diastolic dysfunction and fluid balance in critically ill patients during weaning from mechanical ventilation.

Zapata L, Suarez-Montero JC, López-Garzón PA. Association between diastolic dysfunction and fluid balance in critically ill patients during weaning from mechanical ventilation.. Medicina Intensiva. 2023; 47(12)DOI:10.1016/j.medine.2023.05.012. PMID:37380508. IF:(Q/D).

01/09/2023 Role of ultrasound in acute respiratory failure and in the weaning of mechanical ventilation.

Zapata L, Blancas R, Conejo-Márquez I, García-de-Acilu M. Role of ultrasound in acute respiratory failure and in the weaning of mechanical ventilation.. Medicina Intensiva. 2023; 47(9)DOI:10.1016/j.medine.2023.03.018. PMID:37419839. IF:(Q/D).

01/09/2023 Introduction to the update series: update in intensive care medicine: ultrasound in the critically ill patient. Clinical applications.

Ochagavía A, Fraile V, Zapata L. Introduction to the update series: update in intensive care medicine: ultrasound in the critically ill patient. Clinical applications.. Medicina Intensiva. 2023; 47(9)DOI:10.1016/j.medine.2023.08.001. PMID:37634919. IF:(Q/D).

24/08/2023 Factors associated with the need of parenteral nutrition in critically ill patients after the initiation of enteral nutrition therapy.

Lopez-Delgado JC, Servia-Goixart L, Grau-Carmona T, Bordeje-Laguna L, Portugal-Rodriguez E, Lorencio-Cardenas C, Vera-Artazcoz P, Macaya-Redin L, Martinez-Carmona JF, Marin Corral J, Flordelís-Lasierra JL, Seron-Arbeloa C, Alcazar-Espin MLN, Navas-Moya E, Aldunate-Calvo S, Nieto Martino B, Martinez de Lagran I. Factors associated with the need of parenteral nutrition in critically ill patients after the initiation of enteral nutrition therapy.. Frontiers in Nutrition. 2023; 10DOI:10.3389/fnut.2023.1250305. PMID:37693244. IF:4.000(Q2/3D).

27/03/2023 Study protocol for a randomized controlled trial of Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: the PROMIZING study.

Bosma KJ, Martin CM, Burns KEA, Mancebo Cortes J, Suárez Montero JC, Skrobik Y, Thorpe KE, Amaral ACK, Arabi Y, Basmaji J, Beduneau G, Beloncle F, Carteaux G, Charbonney E, Demoule A, Dres M, Fanelli V, Geagea A, Goligher E, Lellouche F, Maraffi T, Mercat A, Rodriguez PO, Shahin J, Sibley S, Spadaro S, Vaporidi K, Wilcox ME, Brochard L. Study protocol for a randomized controlled trial of Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: the PROMIZING study.. Trials. 2023; 24(1)DOI:10.1186/s13063-023-07163-w. PMID:36973743. IF:2.000(Q3/7D).

01/01/2026 Adverse events associated with the use of flumazenil in the Emergency Department

Ramos, JR, Peláez, MG, Clemente, YC, Requejo, CC, Alcón, EV, Mora, JRR, Blanch, CT, Palomares, AG, Costas, DG. Adverse events associated with the use of flumazenil in the Emergency Department. MEDICINA CLINICA. 2026; 166(1)DOI:10.1016/j.medcli.2025.107312. PMID:41534387. IF:2.100(Q2/3D).

31/12/2025 Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysis

Calle, C, Elez, E, Manzano, JL, Moreno-Martinez, ME, Pericay, C, Graefenhain, R, Ariznavarreta, A, Lizan, L. Value contribution of trifluridine/tipiracil with bevacizumab for the treatment of metastatic colorectal cancer in Catalonia using a multicriteria decision analysis. Journal Of Pharmaceutical Policy And Practice. 2025; 18(1)DOI:10.1080/20523211.2025.2567970. PMID:41415036. IF:(Q/D).

01/01/2024 Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases.

Vilarrasa E, Nicolau J, de la Cueva P, Goday A, Gallardo F, Martorell A, Carrascosa JM. Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases.. Actas Dermo-Sifiliograficas. 2024; 115(1)DOI:10.1016/j.ad.2023.06.017. PMID:37451337. IF:(Q/D).

01/01/2024 Therapeutic outcomes and survival analysis of Extramammary Paget's disease: A multicentre retrospective study of 249 patients.

Escolà H, Llombart B, Escolà-Rodríguez A, Barchino-Ortiz L, Marcoval J, Alcaraz I, Beà-Ardébol S, Toll A, Miñano-Medrano R, Rodríguez-Jiménez P, López-Nuñez M, Ferrándiz-Pulido C, Jaka A, Masferrer E, Aguayo-Ortiz RS, Yébenes M, Arandes-Marcocci J, Ruiz-Salas V, Turrión-Merino L, Just M, Sánchez-Schmidt J, Leal L, Mayo-Martínez F, Haya-Martínez L, Sandoval-Clavijo A, Dradi GG, Delgado Y, Verdaguer-Faja J, López-Castillo D, Pujol RM, Deza G. Therapeutic outcomes and survival analysis of Extramammary Paget's disease: A multicentre retrospective study of 249 patients.. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2024; 90(1)DOI:10.1016/j.jaad.2023.08.088. PMID:37704106. IF:11.800(Q1/1D).

01/12/2023 Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up.

Papp KA, Blauvelt A, Puig L, Ohtsuki M, Beissert S, Gooderham M, Amin AZ, Liu J, Wu T, Azam T, Stakias V, Espaillat R, Sinvhal R, Soliman AM, Pang Y, Chen MM, Lebwohl MG. Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up.. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2023; 89(6)DOI:10.1016/j.jaad.2023.07.1024. PMID:37553030. IF:12.800(Q1/1D).

01/12/2023 Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks.

Egeberg A, Kristensen LE, Puig L, Rich P, Smith SD, Garrelts A, See K, Holzkaemper T, Fotiou K, Schuster C. Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks.. JOURNAL OF DERMATOLOGICAL TREATMENT. 2023; 34(1)DOI:10.1080/09546634.2023.2263108. PMID:37781881. IF:2.900(Q2/4D).

01/11/2023 [[Translated Article]]Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology.

Puig L. [[Translated Article]]Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology.. Actas Dermo-Sifiliograficas. 2023; 114(10)DOI:10.1016/j.ad.2023.09.020. PMID:37778620. IF:(Q/D).

01/10/2023 Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review.

Girolomoni G, Savage L, Gisondi P, Svensson Å, Mahé E, Augustin M, Puig L. Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review.. Dermatology and Therapy. 2023; 13(10)DOI:10.1007/s13555-023-01014-x. PMID:37710078. IF:3.500(Q1/3D).

01/10/2023 The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study.

Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Stratigos A, Trakatelli M, Puig L. The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study.. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37 Suppl 7DOI:10.1111/jdv.18916. PMID:37806003. IF:8.500(Q1/1D).

01/10/2023 Public perception of dermatologists in Europe: Results from a population-based survey

Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Trakatelli M, Puig L, Stratigos A. Public perception of dermatologists in Europe: Results from a population-based survey. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37 Suppl 7DOI:10.1111/jdv.18988. PMID:37806001. IF:8.500(Q1/1D).

01/10/2023 Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the 'burden of skin diseases' EADV project.

Gisondi P, Puig L, Richard MA, Paul C, Nijsten T, Taieb C, Stratigos A, Trakatelli M, Salavastru C. Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the 'burden of skin diseases' EADV project.. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37 Suppl 7DOI:10.1111/jdv.18917. PMID:37806002. IF:8.500(Q1/1D).

01/09/2023 A concept for integrated care pathways for atopic dermatitis-A GA(2) LEN ADCARE initiative.

Zuberbier T, Abdul Latiff A, Aggelidis X, Augustin M, Balan RG, Bangert C, Beck L, Bieber T, Bernstein JA, Bertolin Colilla M, Berardi A, Bedbrook A, Bindslev-Jensen C, Bousquet J, de Bruin-Weller M, Bruscky D, Buyuktiryaki B, Canonica GW, Castro C, Chanturidze N, Chong-Neto HJ, Chu CY, Chularojanamontri L, Cork M, Criado RFJ, Barredo LC, Custovic A, Darsow U, Emurlai A, de Pablo A, Del Giacco S, Girolomoni G, Deleva Jovanova T, Deleuran M, Douladiris N, Duarte B, Dubakiene R, Eller E, Engel-Yeger B, Ensina LF, Filho NR, Flohr C, Fomina D, Francuzik W, Galimberti ML, Giménez-Arnau AM, Godse K, Mortz CG, Gotua M, Hide M, Hoetzenecker W, Hunzelmann N, Irvine A, Jack C, Kanavarou I, Katoh N, Kinaciyan T, Kocatürk E, Kulthanan K, Lapeere H, Lau S, Machado Forti Nastri M, Makris M, Mansour E, Marsland A, Morelo Rocha Felix M, Moschione Castro AP, Nettis E, Nicolas JF, Nosbaum A, Odemyr M, Papapostolou N, Parisi CAS, Paudel S, Peter J, Pokharel P, Puig L, Quint T, Ramon GD, Regateiro F, Ricci G, Rosario C, Sackesen C, Schmid-Grendelmeier P, Serra-Baldrich E, Siemens K, Smith C, Staubach P, Stevanovic K, Su-Kücük Ö, Sussman G, Tavecchio S, Teovska Mitrevska N, Thaci D, Toubi E, Traidl-Hoffmann C, Treudler R, Vadasz Z, van Hofman I, Ventura MT, Wang Z, Werfel T, Wollenberg A, Yang A, Weng Yew Y, Zhao Z, Zwiener R, Worm M. A concept for integrated care pathways for atopic dermatitis-A GA(2) LEN ADCARE initiative.. Clinical and Translational Allergy. 2023; 13(9)DOI:10.1002/clt2.12299. PMID:37746794. IF:4.600(Q2/3D).

01/06/2023 Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis.

Ruiz-Villaverde R, Galán-Gutiérrez M, Llamas-Velasco M, Salgado-Boquete L, Puig L, de la Cueva P, Carrascosa JM. Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis.. Actas Dermo-Sifiliograficas. 2023; 114(6)DOI:10.1016/j.ad.2023.02.016. PMID:36906260. IF:(Q/D).

01/01/2023 Ethnicity and skin conditions in Europe: a large survey from the "Burden of Skin Diseases" EADV project.

Richard MA, Wolkenstein P, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Trakatelli M, Puig L, Stratigos A. Ethnicity and skin conditions in Europe: a large survey from the "Burden of Skin Diseases" EADV project.. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(11)DOI:10.1111/jdv.18994. PMID:36840384. IF:8.500(Q1/1D).

01/03/2022 Practical update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPS) on the Treatment of Psoriasis with Biologic Therapy. Part 1. Concepts and General Management of Psoriasis with Biologic Therapy.

Carrascosa JM, Puig L, Belinchón Romero I, Salgado-Boquete L, Del Alcázar E, Andrés Lencina JJ, Moreno D, de la Cueva P. Practical update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPS) on the Treatment of Psoriasis with Biologic Therapy. Part 1. Concepts and General Management of Psoriasis with Biologic Therapy.. Actas Dermo-Sifiliograficas. 2022; 113(3)DOI:10.1016/j.ad.2021.10.003. PMID:35526919. IF:(Q/D).

01/02/2025 Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)

Abril-Pérez, C, Mansilla-Polo, M, Escutia-Muñoz, B, Sanmartín, O, Garcés, JR, Rodríguez-Prieto, MA, Ruiz-Salas, V, de Eusebio-Murillo, E, Miñano-Medrano, R, González-Sixto, B, Artola-Igarza, JL, Alfaro-Rubio, A, Redondo, P, Delgado-Jiménez, Y, Sánchez-Schmidt, JM, Allende-Markixana, I, Alonso-Pacheco, ML, García-Bracamonte, B, de la Cueva-dobao, P, Navarro-Tejedor, R, Ciudad-Blanco, C, Carnero-González, L, Vázquez-Veiga, H, Cano-Martínez, N, Serra-Guillén, C, Vilarrasa, E, Sánchez-Sambucety, P, López-Estebaranz, JL, Flórez-Menéndez, A, Martorell-Calatayud, A, Gil, P, Morales-Gordillo, V, Toll, A, Ocerin-Guerra, I, Mayor-Arenal, M, Suárez-Fernández, R, Sainz-Gaspar, L, Descalzo, MA, Garcia-Doval, I, Botella-Estrada, R. Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery). JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(2)DOI:10.1111/jdv.20103. PMID:38733285. IF:8.000(Q1/1D).

01/01/2025 Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis

Pesqué, D, Borrego, L, Zaragoza-Ninet, V, Sanz-Sánchez, T, Miquel-Miquel, FJ, González-Pérez, R, Silvestre, JF, Córdoba-Guijarro, S, Carrascosa, JM, Gatica-Ortega, ME, Ruiz-González, I, Mercader-García, P, Tous-Romero, F, de Frutos, FJO, Serra-Baldrich, E, Pastor-Nieto, MA, Rodríguez-Serna, M, Sánchez-Pérez, J, Sánchez-Gilo, A, Melé-Ninot, G, Guillén, PSP, Pujol, RM, Giménez-Arnau, AM. Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(1)DOI:10.1111/jdv.19934. PMID:38411353. IF:8.000(Q1/1D).

01/01/2025 Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa

Garbayo-Salmons, P, Vilarrasa, E, Bassas-Vila, J, Mora-Fernández, V, Fuertes, I, Luque-Luna, M, Fornons-Servent, R, Martin-Ezquerra, G, Aguayo-Ortiz, RS, Ceravalls, J, Mollet, J, Tomás, AG, Masferrer, E, Corral-Magaña, O, Matas-Nadal, C, del Estal, J, Bailón, DF, Calvet, J, Romani, J. Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(1)DOI:10.1111/jdv.20044. PMID:38687278. IF:8.000(Q1/1D).

01/04/2026 Milia-Like Papules and Ulcerated Nodules in a Man With Bartter Syndrome

Carmona-Rocha, E, Subiela, E, Puig, L, Morales-Munera, CE. Milia-Like Papules and Ulcerated Nodules in a Man With Bartter Syndrome. Actas Dermo-Sifiliograficas. 2026; 117(4)DOI:10.1016/j.ad.2025.104557. PMID:41391706. IF:(Q/D).

01/04/2026 Real-World Experience With Secukinumab for Hidradenitis Suppurativa: A Multicenter Retrospective Analysis of 263 Patients From the SECU-SPAIN Study

Martorell, A, Vilarrasa-Rull, E, Fernandez-Crehuet, P, Molina-Leyva, A, Mansilla, M, Garcia-Ruiz, R, Garbayo-Salmons, P, Ortiz-Salvador, JM, Alfageme-Roldan, F, Garcias-Ladaria, J, Bassas-Vila, J, Fuertes-de-Vega, I, Carnero-Gonzalez, L, Almenara-Blasco, M, Torres-Navarro, I, Aguayo-Ortiz, R, Pallares, PG, Fornons-Servent, R, Gracia-Darder, I, Mora-Fernández, V, Corral, O, Pericet-Fernandez, L, Navarro, F, Haselgruber, S, Ochando-Ibernon, G, Menéndez-Parron, A, Masferrer, E, Gamissans, M, Solera-Talamante, M, Moya, M, Imbernon, A, Melgosa, J. Real-World Experience With Secukinumab for Hidradenitis Suppurativa: A Multicenter Retrospective Analysis of 263 Patients From the SECU-SPAIN Study. Actas Dermo-Sifiliograficas. 2026; 117(4)DOI:10.1016/j.ad.2025.104562. PMID:41391709. IF:(Q/D).

01/03/2026 Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology

Puig, L, Carrascosa, JM, Rivera, R, Vilarrasa, E, de la Cueva, P, López-Ferrer, A. Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliograficas. 2026; 117(3)DOI:10.1016/j.ad.2025.104544. PMID:41371399. IF:(Q/D).

01/03/2026 Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study

Mansilla-Polo, M, Pons-Benavent, M, Fernández-Crehuet, P, Vilarrasa, E, Albanell-Fernández, C, Morales-Tedone, E, Rausell-Félix, F, Alcalá-Garcia, R, Matellanes-Palacios, M, Martin-Ezquerra, G, Alfageme, F, Ciudad-Blanco, C, López-Villaescusa, MT, Segura-Palacios, JM, Pascual-Ramirez, JC, Fernández-Diaz, ML, Falkenhain-López, D, Garcia-Gil, M, Agusti-Mejias, A, No-Pérez, N, Naranjo-Guerrero, N, Estenaga-Pérez, A, Garcia-Ruiz, R, Mahiques-Santos, L, Garbayo-Salmons, P, Martorell, A, Escutia-Muñoz, B, Martin-Torregrosa, D, Cuenca-Barrales, C, Paniego, CU, Botella-Estrada, R, Molina-Leyva, A. Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study. Actas Dermo-Sifiliograficas. 2026; 117(3)DOI:10.1016/j.ad.2025.104531. PMID:41354335. IF:(Q/D).

01/03/2026 Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024

Grau-Pérez, M, Mercader-García, P, Giménez-Arnau, AM, Sanz-Sánchez, T, Ninet, VZ, Guijarro, SC, Miquel, FJM, Salvador, JFS, González-Pérez, R, González, IR, Baldrich, ES, Carrascosa, JM, de Frutos, FJO, Serna, MR, Ortega, MEG, Suárez, CP, Triviño, FJN, Chicharro, P, Andreu, M, Gilo, AS, Rodríguez, JJP, Nieto, MAP, Melé-Ninot, G, Guillén, PS, de la Fuente, EG, Elosua-González, M, Munera-Campos, M, Romero, FT, Descalzo, MA, Borrego, L. Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024. CONTACT DERMATITIS. 2026; 94(3)DOI:10.1111/cod.70048. PMID:41365615. IF:4.600(Q1/1D).

01/02/2026 Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort

Ardébol, SB, Pérez-Pastor, GM, Fernández-de-Misa, R, Botella-Estrada, R, Ruiz-Salas, V, Flórez, A, Arenal, MM, González, MJF, Bassas-Freixas, P, Toll, A, Almazán, PV, Arntz, R, Malvehy, J. Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort. Actas Dermo-Sifiliograficas. 2026; 117(2)DOI:10.1016/j.ad.2025.104524. PMID:41352588. IF:(Q/D).

01/02/2026 Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review

Baniandres, O, Franch, IB, Rull, EV, Moya, AI, Pacheco, MLA, Puchades, AM, Sánchez, JPH, Diaz, FJM, Ruiz, AB, Cantero, AG, Lorenzo, EM, Gutierrez, MG, Fernández-Freire, LR, Payeras, AV, Santos, CM, Bel, PH, Ostiz, SH, Montcusi, JP, Salafranca, MA, Segura, PC, Pallas, IM, Masoliver, AA, Manchón, TM, Mucientes, CD, Apetrei, CLS, Martinez, AB, Serrano, JM, Ortega, CP, del Cura, LR, Barragán, IL, Mur, EC, Olivares, MG, Dobao, PD. Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(2)DOI:10.1111/ijd.70053. PMID:40931458. IF:3.200(Q1/3D).

01/02/2026 Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors

Ara-Martín, M, Moreno, C, Ruiz-Villaverde, R, Serra-Baldrich, E, Hernández-Martín, I, Fortes, MD. Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(2)DOI:10.1111/ijd.70033. PMID:40928003. IF:3.200(Q1/3D).

01/01/2026 Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study

Bejarano, L, Grau-Pérez, M, Paíno-Román, M, Muret, MPG, Morillo, M, Muniesa, C, Torre-Castro, J, Estrach, MT, Díez, EA, Belloso, RML, Peñate, Y, Martínez-Mera, C, Botella-Estrada, R, Eceiza, MJM, Romero, PLO, Blanes, M, Fernández-de-Misa, R, Prieto-Torres, L, Amer, MEP, Iznardo, H, Moreno-Vílchez, C, Servitje, O, García-Doval, I, Cañueto, J. Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2026; 40(1)DOI:10.1111/jdv.20638. PMID:40065681. IF:8.000(Q1/1D).

01/01/2026 Chronic Prurigo: Current Knowledge, Treatment Strategies, Future Perspectives, and Unmet Needs

Figueras-Nart, I, Serra-Baldrich, E, Ständer, S. Chronic Prurigo: Current Knowledge, Treatment Strategies, Future Perspectives, and Unmet Needs. ACTA DERMATO-VENEREOLOGICA. 2026; 106DOI:10.2340/actadv.v106.44285. PMID:41508835. IF:3.700(Q1/2D).

01/01/2026 EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis

Marzo-Ortega, H, Harrison, SR, Fragoulis, GE, Michelena, X, Macía-Villa, C, Aydin, SZ, Balanescu, A, Bertheussen, H, Bundy, C, Chimenti, MS, Gisondi, P, Glintborg, B, Gossec, L, Kalyoncu, U, Lubrano, E, Nagy, G, Wagenaar, W, Puig, L, Queiro, R, Rahman, P, Shumnalieva, R, Soriano, ER, van den Bosch, F, Sande, MMGHV, Sepriano, A, Machado, PM, Siebert, S. EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(1)DOI:10.1016/j.ard.2025.10.002. PMID:41168056. IF:20.600(Q1/1D).

01/12/2025 ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa

Grau-Pérez, M, Ciudad, C, Molina-Leyva, A, Martorell, A, Vilarrasa, E, Albert, I, Garcias-Ladaria, J, Melgosa, FJ, Rivera, R, Campos, M, Haselgruber, S, Ochando, G, Pascual, JC, García-Ruiz, R, Alfageme, F. ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa. DERMATOLOGY. 2025; 241(5-6)DOI:10.1159/000546647. PMID:40587963. IF:2.700(Q2/4D).

01/12/2025 REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS

Ferrer, AL, Belinchón, I, Serra, MC, Clua, MG, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).

01/12/2025 UNDERSTANDING PATIENT PRIORITIES IN PSORIASIS TREATMENT: A REVIEW OF KEY DECISION-MAKING DRIVERS

Ferrer, AL, Belinchón, I, Serra, MC, Martínez, LE, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. UNDERSTANDING PATIENT PRIORITIES IN PSORIASIS TREATMENT: A REVIEW OF KEY DECISION-MAKING DRIVERS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).

01/12/2025 HIGHER MORTALITY FOR GENERALIZED PUSTULAR PSORIASIS COMPARED WITH PLAQUE PSORIASIS HIGHLIGHTS THE NEED FOR IMPROVED TREATMENTS: INSIGHTS FROM A META-ANALYSIS

Strober, B, Puig, L, Lebwohl, MG, Lakshminarasimhan, B, Khan, SA, Pillai, N, Kappelhoff, B, Weatherill, A, Warren, RB. HIGHER MORTALITY FOR GENERALIZED PUSTULAR PSORIASIS COMPARED WITH PLAQUE PSORIASIS HIGHLIGHTS THE NEED FOR IMPROVED TREATMENTS: INSIGHTS FROM A META-ANALYSIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).

01/11/2025 Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?

Fernández, CPH, Borrego, L, Arnau, AMG, Sánchez, TS, Carrillo, JMC, Ninet, VZ, Baldrich, ES, Miquel, FJM, Salvador, JFS, Guijarro, SC, Gilo, AS, García, PM, Triviño, FN, Romero, FT, Serna, MR, Ninot, GM, González, IR, de la Fuente, EG, Nieto, MAP, Guillén, PSP, Pérez, JS, Rodríguez, JJP, Ortega, MEG, Pérez, RG, Doval, IG, Descalzo, MAG. Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2024.10.063. PMID:40024601. IF:(Q/D).

01/09/2025 Azathioprine for the Treatment of Chronic Spontaneous Urticaria Refractory to Antihistamines, Omalizumab, and Ciclosporin: A Case Series

Mateu-Arrom, L, Martin, R, Expósito-Serrano, V, Alvarez-Abella, A, Serra-Baldrich, E, Spertino, J. Azathioprine for the Treatment of Chronic Spontaneous Urticaria Refractory to Antihistamines, Omalizumab, and Ciclosporin: A Case Series. Actas Dermo-Sifiliograficas. 2025; 116(8)DOI:10.1016/j.ad.2025.05.022. PMID:40480489. IF:(Q/D).

01/09/2025 Similarity of efficacy of SB17 to reference ustekinumab for moderate-to-severe psoriasis through 12 weeks in different demographic and comorbidity subgroups

Feldman, SR, Sanz, LP, Girolomoni, G, Jo, SJ, Jung, H, Jung, J. Similarity of efficacy of SB17 to reference ustekinumab for moderate-to-severe psoriasis through 12 weeks in different demographic and comorbidity subgroups. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:. PMID:. IF:11.800(Q1/1D).

01/09/2025 Bimekizumab achievement of 'super response' using a previously published definition in moderate to severe plaque psoriasis: Results from four phase 3/3b trials

Lebwohl, M, Langley, RG, Strober, B, Thaçi, D, Armstrong, A, Gordon, KB, Puig, L, Davies, O, Peterson, L, Davis, L, Warren, RB. Bimekizumab achievement of 'super response' using a previously published definition in moderate to severe plaque psoriasis: Results from four phase 3/3b trials. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:. PMID:. IF:11.800(Q1/1D).

01/07/2025 Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study

Ceravalls, J, Giménez-Arnau, AM, Exposito-Serrano, V, Chico, NF, Moya, AL, Bielsa, I, Ribó, P, Mascaró-Hereza, B, Bonfill-Orti, M, Spertino, J, Serra, E, Baliu-Piqué, C, Melé-Ninot, G. Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study. Actas Dermo-Sifiliograficas. 2025; 116(7)DOI:10.1016/j.ad.2024.08.014. PMID:. IF:(Q/D).

01/06/2025 Surgical Approach to Hidradenitis Suppurativa

Mateu-Arrom, L, Puig, L, Vilarrasa, E. Surgical Approach to Hidradenitis Suppurativa. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2024.10.061. PMID:40185225. IF:(Q/D).

01/06/2025 Bimekizumab clinical efficacy in impactful body regions and health-related quality of life in patients with plaque psoriasis: Data from four phase 3/3b comparator-controlled trial periods

Smith, A, Armstrong, AW, Elewski, B, Rich, P, Augustin, M, Carrascosa, JM, Vender, R, Lambert, J, Pinto, JML, Hoepken, B, Kavanagh, S, Puig, L. Bimekizumab clinical efficacy in impactful body regions and health-related quality of life in patients with plaque psoriasis: Data from four phase 3/3b comparator-controlled trial periods. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2025; 66DOI:. PMID:. IF:1.800(Q3/6D).

01/04/2025 Real-world Efficacy of Brodalumab in Patients with moderate to severe Plaque Psoriasis, in Patients with BMI>30 and BMI=30, BROACTIVE: 2-year Results

Escalas, J, Armesto, S, Abalde, T, Blanco, IR, Blanco, MR, Herrera-Acosta, E, Puig, L, Morales, AM, Ferrán-Farrés, M, Auhage, E, Ribera, M. Real-world Efficacy of Brodalumab in Patients with moderate to severe Plaque Psoriasis, in Patients with BMI>30 and BMI=30, BROACTIVE: 2-year Results. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).

01/04/2025 Absolute EASI response achieved by lebrikizumab over 16 weeks in patients with moderate-to-severe atopic dermatitis

Thaçi, D, Puig, L, Papp, K, Gold, LS, Fernández-Peñas, P, Huang, YH, Dossenbach, M, Falques, M, Agell, H, Schönherr, F, Vestergaard, C. Absolute EASI response achieved by lebrikizumab over 16 weeks in patients with moderate-to-severe atopic dermatitis. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).

01/01/2025 EFFECTIVENESS OF 12-MONTHS TRALOKINUMAB TREATMENT IN 124 ADULTS WITH ATOPIC DERMATITIS WITH GENITAL INVOLVEMENT: FINAL REAL-WORLD DATA FROM THE PROSPECTIVE, NON-INTERVENTIONAL, INTERNATIONAL, SINGLE-COHORT TRACE STUDY

Ameen, A, Serra-Baldrich, E, Arm-Strong, A, Festini, T, Vinther, F, Vittrup, I, Wiseman, MC. EFFECTIVENESS OF 12-MONTHS TRALOKINUMAB TREATMENT IN 124 ADULTS WITH ATOPIC DERMATITIS WITH GENITAL INVOLVEMENT: FINAL REAL-WORLD DATA FROM THE PROSPECTIVE, NON-INTERVENTIONAL, INTERNATIONAL, SINGLE-COHORT TRACE STUDY. ACTA DERMATO-VENEREOLOGICA. 2025; 105DOI:. PMID:. IF:3.700(Q1/2D).

12/01/2024 Student survey after ten years of continuous blended teaching of echocardiography.

Parra VM, Fita G, Azqueta M, González M, Aranda F, Maestre M, Silva J, Hortal J, Morales D, Bórquez E, Adasme F, Real MI, Mercadal J, Zelada P, Riobó G, Galdames K, Domenech RJ. Student survey after ten years of continuous blended teaching of echocardiography.. Revista Espanola De Anestesiologia Y Reanimacion. 2024; 71(1)DOI:10.1016/j.redare.2023.05.004. PMID:37683971. IF:(Q/D).

01/12/2023 Prediction of Acute Myocardial Injury in Noncardiac Surgery in Patients at Risk for Major Adverse Cardiovascular and Cerebrovascular Events: A Multivariable Risk Model.

Mases A, Beltrán de Heredia S, Gallart L, Román L, Bosch L, Núñez M, Rueda M, Recasens L, Sabaté S. Prediction of Acute Myocardial Injury in Noncardiac Surgery in Patients at Risk for Major Adverse Cardiovascular and Cerebrovascular Events: A Multivariable Risk Model.. ANESTHESIA AND ANALGESIA. 2023; 137(6)DOI:10.1213/ANE.0000000000006469. PMID:37043386. IF:4.600(Q1/2D).

26/08/2023 Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II).

Llau JV, Aldecoa C, Guasch E, Marco P, Marcos-Neira P, Paniagua P, Páramo JA, Quintana M, Rodríguez-Martorell FJ, Serrano A. Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II).. Revista Espanola De Anestesiologia Y Reanimacion. 2023; 70(7)DOI:10.1016/j.redare.2023.08.001. PMID:37640281. IF:(Q/D).

01/08/2023 Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II).

Llau JV, Aldecoa C, Guasch E, Marco P, Marcos-Neira P, Paniagua P, Páramo JA, Quintana M, Rodríguez-Martorell FJ, Serrano A. Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II).. Medicina Intensiva. 2023; 47(8)DOI:10.1016/j.medine.2023.03.019. PMID:37536911. IF:(Q/D).

01/07/2023 Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic.

Castellarnau S, Gaya JM, Espinosa J, Sierra P, Huguet J, Palou J, Hernando D, Sabaté S, Breda A. Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic.. Actas Urologicas Espanolas. 2023; 47(6)DOI:10.1016/j.acuroe.2023.01.006. PMID:36842706. IF:(Q/D).